Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07581158 · ClinicalTrials.gov registry record · NA
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07581158 is a NA study that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 40 participants.
The verdict
NCT07581158, a NA study, has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using wearable brain imaging, functional near-infrared spectroscopy (fNIRS), together with a brain-based 4-week text-messaging intervention. The investigators will examine how these interventions may influence inhibitory control and eating disorder symptoms in women with bulimia nervosa.
Interventions
- OTHER Real fNIRS Neurofeedback
- OTHER Sham-Control fNIRS Neurofeedback
- OTHER SmartPhone Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04-25 |
| Est. Completion | 2028-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07581158
The ClinicalTrials.gov registry entry for NCT07581158 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Real fNIRS Neurofeedback is the first listed.
NCT07581158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07581158 about?
NCT07581158 is a clinical study titled "Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa". The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using wearable brain imaging, functional near-infrared spectroscopy (fNIRS), together with a brain-based 4-week text-messaging intervention. The i...
What is the current status of trial NCT07581158?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-04-25. Estimated completion is 2028-12-14.
What interventions are being tested in trial NCT07581158?
The interventions under investigation include: Real fNIRS Neurofeedback (OTHER), Sham-Control fNIRS Neurofeedback (OTHER), SmartPhone Intervention (OTHER).
Who is sponsoring clinical trial NCT07581158?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.